• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒病 2019 成人的临床特征和结局:文献的系统评价和汇总分析。

Clinical features and outcomes of adults with coronavirus disease 2019: A systematic review and pooled analysis of the literature.

机构信息

Department of Cardiology, Royal Stoke University Hospital, Stoke-on-Trent, UK.

Smart Innovation Hub, Keele University, Stoke-on-Trent, UK.

出版信息

Int J Clin Pract. 2021 Mar;75(3):e13725. doi: 10.1111/ijcp.13725. Epub 2020 Nov 3.

DOI:10.1111/ijcp.13725
PMID:32965728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7536970/
Abstract

BACKGROUND

The 2019 coronavirus disease (COVID-19) has become a global pandemic and the published literature describing the virus has grown exponentially.

METHODS

We conducted a systematic review of the literature to identify the symptoms, comorbidities present, radiological features and outcomes for adults testing positive for COVID-19 admitted to hospital. The results across multiple studies were numerically pooled to yield total estimated.

RESULTS

A total of 45 studies were included in this review with 14 358 adult participants (average age 51 years, male 51%). The pooled findings suggest that the most common symptom among patients was fever (81.2%) followed by cough (62.9%), fatigue (38.0%) and anorexia/loss of appetite (33.7%). The comorbidities that were most prevalent among patients with the virus were hypertension (19.1%), cardiovascular disease (17.9%), endocrine disorder (9.3%) and diabetes (9.2%). Abnormal chest X-ray findings were present in 27.7% of patients and ground-glass opacity was demonstrated on chest computerized tomography in 63.0% of patients. The most frequent adverse outcomes were acute respiratory distress syndrome (27.4%), acute cardiac injury (16.2%) and acute kidney injury (12.6%). Death occurred in 8.2% of patients and 16.3% required intensive care admission and 11.7% had mechanical ventilation. Bacterial or secondary infections affected 8.5% of patients and 6.9% developed shock.

CONCLUSIONS

COVID-19 most commonly presents with fever, cough, fatigue and anorexia and among patients with existing hypertension and cardiovascular disease. It is important as serious adverse outcomes can develop such as acute respiratory distress syndrome, acute cardiac injury, acute kidney injury and death.

摘要

背景

2019 年冠状病毒病(COVID-19)已成为全球大流行,描述该病毒的已发表文献呈指数级增长。

方法

我们对文献进行了系统回顾,以确定住院的 COVID-19 阳性成年人的症状、合并症、影像学特征和转归。对多项研究的结果进行数值汇总,以得出总估计值。

结果

本综述共纳入 45 项研究,共有 14358 名成年参与者(平均年龄 51 岁,男性 51%)。汇总结果表明,患者最常见的症状是发热(81.2%),其次是咳嗽(62.9%)、乏力(38.0%)和食欲不振(33.7%)。患有该病毒的患者中最常见的合并症是高血压(19.1%)、心血管疾病(17.9%)、内分泌紊乱(9.3%)和糖尿病(9.2%)。异常的胸部 X 线表现见于 27.7%的患者,63.0%的患者胸部计算机断层扫描显示磨玻璃影。最常见的不良结局是急性呼吸窘迫综合征(27.4%)、急性心脏损伤(16.2%)和急性肾损伤(12.6%)。患者中有 8.2%死亡,16.3%需要重症监护病房收治,11.7%需要机械通气。细菌或继发性感染影响 8.5%的患者,6.9%发生休克。

结论

COVID-19 最常表现为发热、咳嗽、乏力和食欲不振,在患有高血压和心血管疾病的患者中更为常见。重要的是,严重的不良结局可能会发展,如急性呼吸窘迫综合征、急性心脏损伤、急性肾损伤和死亡。

相似文献

1
Clinical features and outcomes of adults with coronavirus disease 2019: A systematic review and pooled analysis of the literature.新型冠状病毒病 2019 成人的临床特征和结局:文献的系统评价和汇总分析。
Int J Clin Pract. 2021 Mar;75(3):e13725. doi: 10.1111/ijcp.13725. Epub 2020 Nov 3.
2
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征:一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
4
Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis.新型冠状病毒肺炎大流行期间的流行病学、临床和实验室研究结果:系统评价和荟萃分析。
BMC Infect Dis. 2020 Aug 31;20(1):640. doi: 10.1186/s12879-020-05371-2.
5
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.新德里一家三级医疗中心SARI病房中新冠病毒患者的临床和流行病学特征
J Assoc Physicians India. 2020 Jul;68(7):19-26.
6
Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.在新冠疫情早期,一家筛查诊所的冠状病毒病(COVID-19)病例的流行病学和临床特征:一项单中心研究。
J Med Microbiol. 2020 Aug;69(8):1114-1123. doi: 10.1099/jmm.0.001231.
7
Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms.新型冠状病毒肺炎的临床表现:以上呼吸道症状为重点的系统评价
Ear Nose Throat J. 2020 Nov;99(9):569-576. doi: 10.1177/0145561320920762. Epub 2020 Apr 13.
8
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.在底特律市区的一系列患者中,与 2019 年冠状病毒病相关的临床特征和发病率。
JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270.
9
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.新冠肺炎住院患者中心脏损伤与死亡的相关性研究:中国武汉。
JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.
10
Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.巴西原住民中由严重急性呼吸综合征冠状病毒2感染或其他病原体引起的严重急性呼吸综合征:一项关于冠状病毒病(COVID)-19大流行第一年的观察性研究。
Lancet Reg Health Am. 2022 Apr;8:100177. doi: 10.1016/j.lana.2021.100177. Epub 2022 Jan 7.

引用本文的文献

1
Predictors of dropping out from a home tele-exercise programme: A cohort study derived from a randomised controlled trial.家庭远程锻炼计划退出的预测因素:一项源自随机对照试验的队列研究。
Health Promot Perspect. 2024 Oct 31;14(3):238-247. doi: 10.34172/hpp.42935. eCollection 2024.
2
Investigating the effects of remdesivir on corrected QT interval in patients with severe COVID-19 disease: a historical cohort study.研究瑞德西韦对重症新型冠状病毒肺炎患者校正QT间期的影响:一项历史性队列研究。
BMC Cardiovasc Disord. 2024 Dec 4;24(1):700. doi: 10.1186/s12872-024-04380-2.
3
Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Vaccination for Negative Conversion Time of Nucleic Acid in Nonsevere COVID-19 Patients Infected by SARS-CoV-2 Omicron Variant.中性粒细胞与淋巴细胞比值和疫苗接种对感染 SARS-CoV-2 奥密克戎变异株的非重症 COVID-19 患者核酸转阴时间的预后价值。
Int J Clin Pract. 2023 Sep 25;2023:9576855. doi: 10.1155/2023/9576855. eCollection 2023.
4
The impact of COVID-19 on the patient, clinician, healthcare services and society: A patient pathway review.COVID-19 对患者、临床医生、医疗服务和社会的影响:患者路径回顾。
J Med Virol. 2022 Aug;94(8):3634-3641. doi: 10.1002/jmv.27758. Epub 2022 Apr 18.
5
Sex Differences in Use of Low Tidal Volume Ventilation in COVID-19-Insights From the PRoVENT-COVID Study.COVID-19中低潮气量通气使用的性别差异——来自PRoVENT-COVID研究的见解
Front Med (Lausanne). 2022 Jan 3;8:780005. doi: 10.3389/fmed.2021.780005. eCollection 2021.
6
Incidence of cardiac complications following COVID-19 infection: An umbrella meta-analysis study.新冠病毒感染后心脏并发症的发生率:一项伞式荟萃分析研究。
Heart Lung. 2022 Mar-Apr;52:136-145. doi: 10.1016/j.hrtlng.2022.01.001. Epub 2022 Jan 10.
7
The Anti-COVID-19 Drug Remdesivir Promotes Oncogenic Herpesvirus Reactivation through Regulation of Intracellular Signaling Pathways.抗新冠病毒药物瑞德西韦通过调节细胞内信号通路促进致癌疱疹病毒激活。
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0239521. doi: 10.1128/aac.02395-21. Epub 2022 Jan 18.
8
COVID-19 and chronic kidney disease: an updated overview of reviews.COVID-19 与慢性肾脏病:系统评价的更新概述。
J Nephrol. 2022 Jan;35(1):69-85. doi: 10.1007/s40620-021-01206-8. Epub 2022 Jan 11.
9
Evaluation of biochemical characteristics of 183 COVID-19 patients: A retrospective study.183例新冠肺炎患者生化特征评估:一项回顾性研究。
Gene Rep. 2022 Mar;26:101448. doi: 10.1016/j.genrep.2021.101448. Epub 2021 Nov 27.
10
A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.一项随机对照试验,旨在测试 Fit after COVID 的疗效,Fit after COVID 是一种针对 COVID-19 后严重感染后疲劳的认知行为疗法(ReCOVer):研究方案。
Trials. 2021 Dec 2;22(1):867. doi: 10.1186/s13063-021-05569-y.

本文引用的文献

1
Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system.美国一家大型医疗系统中新冠病毒疾病(COVID-19)住院患者的早期临床和社会人口学经验。
EClinicalMedicine. 2020 Sep;26:100504. doi: 10.1016/j.eclinm.2020.100504. Epub 2020 Aug 19.
2
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
3
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征:前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
4
A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients.一项关于住院成年患者中严重急性呼吸综合征冠状病毒 2 感染危险因素的回顾性研究。
Pol Arch Intern Med. 2020 May 29;130(5):390-399. doi: 10.20452/pamw.15312. Epub 2020 Apr 24.
5
Self-reported olfactory loss associates with outpatient clinical course in COVID-19.自我报告的嗅觉丧失与 COVID-19 门诊临床过程相关。
Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831. doi: 10.1002/alr.22592. Epub 2020 Jun 7.
6
Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.新冠肺炎患者中受抑制的 T 细胞介导的免疫:来自中国武汉的临床回顾性研究。
J Infect. 2020 Jul;81(1):e51-e60. doi: 10.1016/j.jinf.2020.04.012. Epub 2020 Apr 18.
7
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China.中国武汉 221 例 COVID-19 患者的临床特征和短期预后。
J Clin Virol. 2020 Jun;127:104364. doi: 10.1016/j.jcv.2020.104364. Epub 2020 Apr 9.
8
Epidemiology and clinical features of COVID-19: A review of current literature.新型冠状病毒肺炎的流行病学和临床特征:文献复习。
J Clin Virol. 2020 Jun;127:104357. doi: 10.1016/j.jcv.2020.104357. Epub 2020 Apr 10.
9
Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury.对发生肝损伤的新型冠状病毒肺炎患者临床特征及预后的多中心分析
J Hepatol. 2020 Aug;73(2):455-458. doi: 10.1016/j.jhep.2020.04.010. Epub 2020 Apr 17.
10
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.中国武汉 COVID-19 患者疾病严重程度、无改善和死亡率的危险因素。
Clin Microbiol Infect. 2020 Jun;26(6):767-772. doi: 10.1016/j.cmi.2020.04.012. Epub 2020 Apr 15.